Occupational lung diseases in Australia

Ryan F Hoy and Fraser Brims
Med J Aust 2017; 207 (10): . || doi: 10.5694/mja17.00601
Published online: 13 November 2017



  • Occupational exposures are an important determinant of respiratory health. International estimates note that about 15% of adult-onset asthma, 15% of chronic obstructive pulmonary disease and 10–30% of lung cancer may be attributable to hazardous occupational exposures. One-quarter of working asthmatics either have had their asthma caused by work or adversely affected by workplace conditions.
  • Recently, cases of historical occupational lung diseases have been noted to occur with new exposures, such as cases of silicosis in workers fabricating kitchen benchtops from artificial stone products.
  • Identification of an occupational cause of a lung disease can be difficult and requires maintaining a high index of suspicion. When an occupational lung disease is identified, this may facilitate a cure and help to protect coworkers.
  • Currently, very little information is collected regarding actual cases of occupational lung diseases in Australia. Most assumptions about many occupational lung diseases are based on extrapolation from overseas data. This lack of information is a major impediment to development of targeted interventions and timely identification of new hazardous exposures.
  • All employers, governments and health care providers in Australia have a responsibility to ensure that the highest possible standards are in place to protect workers’ respiratory health.


  • 1 Monash University, Melbourne, VIC
  • 2 Cabrini Medical Centre, Melbourne, VIC
  • 3 Sir Charles Gairdner Hospital, Perth, WA
  • 4 Curtin University, Perth, WA


Competing interests:

No relevant disclosures.

  • 1. Walters GI, McGrath EE, Ayres JG. Audit of the recording of occupational asthma in primary care. Occup Med (Lond) 2012; 62: 570-573.
  • 2. Australian Safety and Compensation Council. Occupational respiratory diseases in Australia. Canberra: Commonwealth of Australia, 2006. (accessed June 2017).
  • 3. Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest 2008; 134(3 Suppl): 1S-41S.
  • 4. Sama SR, Milton DK, Hunt PR, et al. Case-by-case assessment of adult-onset asthma attributable to occupational exposures among members of a health maintenance organization. J Occup Environ Med 2006; 48: 400-407.
  • 5. Toren K, Blanc PD. Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fraction. BMC Pulm Med 2009; 9: 7.
  • 6. Johnson A, Toelle BG, Yates D, et al. Occupational asthma in New South Wales (NSW): a population-based study. Occup Med (Lond) 2006; 56: 258-262.
  • 7. Elder D, Abramson M, Fish D, et al. Surveillance of Australian workplace Based Respiratory Events (SABRE): notifications for the first 3.5 years and validation of occupational asthma cases. Occup Med (Lond) 2004; 54: 395-399.
  • 8. Vandenplas O. Socioeconomic impact of work-related asthma. Expert Rev Pharmacoecon Outcomes Res 2008; 8: 395-400.
  • 9. Anees W, Moore VC, Burge PS. FEV1 decline in occupational asthma. Thorax 2006; 61: 751-755.
  • 10. Malo JL, Tarlo SM, Sastre J, et al. An official American Thoracic Society Workshop Report: presentations and discussion of the fifth Jack Pepys Workshop on Asthma in the Workplace. Comparisons between asthma in the workplace and non-work-related asthma. Ann Am Thorac Soc 2015; 12: S99-S110.
  • 11. Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med 2014; 370: 640-649.
  • 12. Hoy RF, Burgess JA, Benke G, et al. Occupational exposures and the development of new-onset asthma: a population-based cohort study from the ages of 13 to 44 years. J Occup Environ Med 2013; 55: 235-239.
  • 13. Fritschi L, Crewe J, Darcey E, et al. The estimated prevalence of exposure to asthmagens in the Australian workforce, 2014. BMC Pulm Med 2016; 16: 48.
  • 14. Vandenplas O, Dressel H, Nowak D, et al. What is the optimal management option for occupational asthma? Eur Respir Rev 2012; 21: 97-104.
  • 15. Landrigan PJ, Lioy PJ, Thurston G, et al. Health and environmental consequences of the world trade center disaster. Environ Health Perspect 2004; 112: 731-739.
  • 16. Brooks SM. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 1985; 88: 376.
  • 17. Tarlo SM. Irritant-induced asthma in the workplace. Curr Allergy Asthma Rep 2014; 14: 406.
  • 18. Henneberger PK, Redlich CA, Callahan DB, et al. An official American Thoracic Society statement: work-exacerbated asthma. Am J Respir Crit Care Med 2011; 184: 368-378.
  • 19. Fishwick D. Work aggravated asthma; a review of the recent evidence. Br Med Bull 2014; 110: 77-88.
  • 20. Hoy R. Work-related laryngeal syndromes. Curr Opin Allergy Clin Immunol 2012; 12: 95-101.
  • 21. Hoy RF, Ribeiro M, Anderson J, et al. Work-associated irritable larynx syndrome. Occup Med (Lond) 2010; 60: 546-551.
  • 22. Blanc PD, Toren K. Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an update. Int J Tuberc Lung Dis 2007; 11: 251-257.
  • 23. Ryu JY, Sunwoo YE, Lee SY, et al. Chronic obstructive pulmonary disease (COPD) and vapors, gases, dusts, or fumes (VGDF): a meta-analysis. COPD 2015; 12: 374-380.
  • 24. Kraim-Leleu M, Lesage FX, Drame M, et al. Occupational risk factors for COPD: a case-control study. PLoS One 2016; 11: e0158719.
  • 25. Bang KM. Chronic obstructive pulmonary disease in nonsmokers by occupation and exposure: a brief review. Curr Opin Pulm Med 2015; 21: 149-154.
  • 26. De Matteis S, Jarvis D, Hutchings S, et al. Occupations associated with COPD risk in the large population-based UK Biobank cohort study. Occup Environ Med 2016; 73: 378-384.
  • 27. Kreiss K, Gomaa A, Kullman G, et al. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 2002; 347: 330-338.
  • 28. Holden VK, Hines SE. Update on flavoring-induced lung disease. Curr Opin Pulm Med 2016; 22: 158-164.
  • 29. Coultas DB, Zumwalt RE, Black WC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967-972.
  • 30. Litow FK, Petsonk EL, Bohnker BK, et al. Occupational interstitial lung diseases. J Occup Environ Med 2015; 57: 1250-1254.
  • 31. Zosky GR, Hoy RF, Silverstone EJ, et al. Coal workers’ pneumoconiosis: an Australian perspective. Med J Aust 2016; 204: 414-418. <MJA full text>
  • 32. Smith DR, Leggat PA. 24 years of pneumoconiosis mortality surveillance in Australia. J Occup Health 2006; 48: 309-313.
  • 33. Si S, Carey RN, Reid A, et al. The Australian Work Exposures Study: prevalence of occupational exposure to respirable crystalline silica. Ann Occup Hyg 2016; 60: 631-637.
  • 34. Cooper JH, Johnson DL, Phillips ML. Respirable silica dust suppression during artificial stone countertop cutting. Ann Occup Hyg 2015; 59: 122-126.
  • 35. Matar E, Frankel A, Blake LKM, et al. Complicated silicosis resulting from occupational exposure to engineered stone products. Med J Aust 2017; 206: 385-386. <MJA full text>
  • 36. Pushnoy L. Outbreak of silicosis in Israel. EU-Israel Workshop on issues associated with silica and artificial stone. 28 Jan 2015; Bilbao, Spain. (accessed June 2017).
  • 37. Musk AW, de Klerk NH, Brims FJH. Asbestos-related non-malignant pleural disease and mesothelioma. In: Newman Taylor A, Cullinan P, Blanc P, Pickering A, editors. Parkes’ occupational lung disorders. 4th ed. Boca Raton: CRC Press, 2016: 171-187.
  • 38. Safe Work Australia. Asbestos. (accessed Aug 2017).
  • 39. Brims FJ, Murray CP, de Klerk N, et al. Ultra-low-dose chest computer tomography screening of an asbestos-exposed population in Western Australia. Am J Respir Crit Care Med 2015; 191: 113-116.
  • 40. Murray CP, Wong PM, Teh J, et al. Ultra low dose CT screen-detected non-malignant incidental findings in the Western Australian Asbestos Review Program. Respirology 2016; 21: 1419-1424.
  • 41. Musk AW, de Klerk N, Brims F. Mesothelioma in Australia: a review. Med J Aust 2017; 207: 449-452.
  • 42. Hillerdal G, Lindgren A. Pleural plaques: correlation of autopsy findings to radiographic findings and occupational history. Eur J Respir Dis 1980; 61: 315-319.
  • 43. Paris C, Thierry S, Brochard P, et al. Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. Eur Respir J 2009; 34: 72-79.
  • 44. Weill D, Dhillon G, Freyder L, et al. Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA. Eur Respir J 2011; 38: 376-383.
  • 45. Broderick A, Fuortes LJ, Merchant JA, et al. Pleural determinants of restrictive lung function and respiratory symptoms in an asbestos-exposed population. Chest 1992; 101: 684-691.
  • 46. Clin B, Paris C, Ameille J, et al. Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis? Thorax 2011; 66: 985-991.
  • 47. de Klerk NH, Cookson WOC, Musk AW, et al. Natural-history of pleural thickening after exposure to crocidolite. Br J Ind Med 1989; 46: 461-467.
  • 48. Cotes JE, King B. Relationship of lung function to radiographic reading (ILO) in patients with asbestos related lung disease. Thorax 1988; 43: 777-783.
  • 49. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004; 170: 691-715.
  • 50. World Health Organization. Environmental and occupational cancers. Fact sheet no. 350, March 2011. Geneva: WHO, 2011.
  • 51. Fritschi L, Driscoll T. Cancer due to occupation in Australia. Aust N Z J Public Health 2006; 30: 213-219.
  • 52. Markowitz SB, Levin SM, Miller A, et al. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am J Respir Crit Care Med 2013; 188: 90-96.
  • 53. de Klerk NH, Musk B, Armstrong B, et al. Crocidolite, radiographic asbestosis and subsequent lung cancer. Br J Ind Med 1991; 48: 412-417.
  • 54. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Diesel and gasoline engine exhausts and some nitroarenes. IARC Monogr Eval Carcinog Risks Hum 2014; 105: 9-699.
  • 55. Peters S, Carey RN, Driscoll TR, et al. The Australian Work Exposures Study: prevalence of occupational exposure to diesel engine exhaust. Ann Occup Hyg 2015; 59: 600-608.
  • 56. Brims F, McWilliams A, Fong K. Lung cancer screening in Australia: progress or procrastination? Med J Aust 2016; 204: 4-5. <MJA full text>
  • 57. Australian Government Department of Health Standing Committee on Screening. Position statement: lung cancer screening using low-dose computed tomography. 2015. (accessed July 2017).
  • 58. Cancer Australia. Risk factors for lung cancer: an overview of the evidence. Sydney: Cancer Australia, 2014. (accessed Aug 2017).
  • 59. Heffler E, Pizzimenti S, Guida G, et al. Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. J Asthma 2015; 52: 931-934.
  • 60. Newman LS. Occupational illness. N Engl J Med 1995; 333: 1128-1134.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.